Zevia PBC

Zevia PBC has a market capitalization of $95.39 million and a price-to-book ratio of 1.87, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 2.08, suggesting it has sufficient short-term assets to cover its liabilities. However, the company reported negative operating cash flow of -$4.70 million and free cash flow of -$10.57 million, indicating a cash outflow from operations. Profitability metrics show that Zevia PBC is currently unprofitable, with a net loss of -$9.92 million and an operating loss of -$11.79 million. The company's return on equity is -19.44%, and its return on assets is -15.59%, both significantly below the industry median for non-alcoholic beverage companies. Gross profit of $77.42 million represents 47.99% of revenue, which is in line with the industry average for similar companies. Zevia PBC operates as a single business segment, with all revenue derived from the sale of its non-alcoholic beverages. The company does not disclose geographic revenue breakdowns, but its operations are primarily based in the United States. This lack of geographic diversification may expose the company to regional economic or regulatory risks. The company's revenue for the latest period was $161.26 million, and while no specific growth rate is provided, the company's outlook for the current fiscal year suggests a continuation of its current trajectory. Analysts have provided a wide range of price targets, from $1.25 to $6.00, with a mean of $4.18 and a median of $5.00, indicating a high degree of uncertainty about the company's future performance. Zevia PBC has a low risk of dilution, with no immediate filing-based liquidity or dilution flags detected. The company has no long-term debt, and its capital structure is entirely equity-based, with $51.04 million in total equity and $12.58 million in total liabilities. The company's capital expenditures were -$307,000, indicating a small outlay for property, plant, and equipment. Recent events include the publication of analyst estimates and price targets, which reflect a mixed sentiment among analysts. The mean recommendation is 2.14, with one strong buy, four buy, and two hold ratings. No recent filings or transcripts have been disclosed that would indicate significant operational or strategic changes.